Phase II clinical trial of Cetuximab with Fluorouracil therapy for patients refractory or intolerable to Oxaliplatin and Irinotecan with KRAS wild-type unresectable/recurrent colorectal cancer
Phase of Trial: Phase II
Latest Information Update: 02 Jul 2018
At a glance
- Drugs Cetuximab (Primary) ; Fluorouracil (Primary) ; Capecitabine; Folinic acid; Gimeracil/oteracil/tegafur; Tegafur/uracil
- Indications Colorectal cancer
- Focus Therapeutic Use
- 25 Jun 2018 Status changed from recruiting to discontinued.
- 16 Jul 2012 New trial record
- 01 Jul 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.